Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Recombinant Proteins
  4. NBC122617

Novus Biologicals™ Recombinant Human PLA2G16/HRASLS3 Protein
SDP

Catalog No. NBC122617 Shop All R&D Systems Products
Change view
Click to view available options
0.1mg; Unlabeled
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No.
NBC122617 0.1mg; Unlabeled
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. NBC122617 Supplier Novus Biologicals™ Supplier No. NBC122617
Only null left
Add to Cart
Add to Cart

Description

Highly purified. Generating reliable and reproducible results.

An un-tagged recombinant protein corresponding to the amino acids1-133 of PLA2G16/HRASLS3 The Recombinant Human PLA2G16/HRASLS3 Protein is derived from E. coli. The Recombinant Human PLA2G16/HRASLS3 Protein has been validated for the following applications: SDS-Page.

Specifications

Accession Number NP_001121675
For Use With (Application) ELISA, SDS-PAGE
Formulation Liquid. In 20mM Tris-HCl buffer (pH 8.0)
Gene ID (Entrez) 1145
Molecular Weight (g/mol) 14.9kDa
Name Nicotinic Acetylcholine Receptor epsilon Protein
Purification Method Protein
Immunogen MRAPIPEPKP GDLIEIFRPF YRHWAIYVGD GYVVHLAPPS EVAGAGAASV MSALTDKAIV KKELLYDVAG SDKYQVNNKH DDKYSPLPCS KIIQRAEELV GQEVLYKLTS ENCEHFVNEL RYGVARSDQV RDV
Storage Requirements −80°C. Avoid freeze-thaw cycles.
Cross Reactivity Human
Purity or Quality Grade >95%, by SDS-PAGE
Show More Show Less
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.